We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Use of sildenafil and l-arginine in an experimental rat model for the prevention of neonatal necrotizing enterocolitis.
- Authors
Moreira, Gabriela Araujo; Dias, André Ivan Bradley dos Santos; Cadena, Silvia Maria Suter Correia; Corrêa-Ferreira, Marília Locatelli; Ioshii, Sergio Ossamu; Fachin, Camila Girardi
- Abstract
Necrotizing enterocolitis (NEC) has a 45% mortality in neonatal intensive care units. This paper aimed to evaluate the isolated and combined effects of sildenafil and l-arginine in the prevention of necrotizing enterocolitis. Neonatal rats were fed formula milk and submitted to hypoxia under a 100% N2 atmosphere for 70 s. Then, animals were subjected to hypothermia (4 °C for 10 min), twice a day for 3 days. Forty neonatal rats were divided into five groups: negative control—not submitted to the protocol (n = 5), sildenafil group—NEC protocol (n = 9), l-arginine group—NEC protocol (n = 9), l-arginine and sildenafil group—NEC protocol (n = 9) and positive control—NEC protocol and intraperitoneal saline solution (n = 8). Jejunum and terminal ileus were removed for histopathologic and immunohistochemical Ki-67 analysis. Kruskal–Wallis test was used to analyze mortality, survival, body weight, intestinal injury score and Ki-67 proliferation index. All animals submitted to the protocol developed enterocolitis. Mortality rate was higher in group that received only l-arginine (p = 0.0293). The Ki-67 analysis showed a higher proliferative index in groups that received interventional drugs (p = 0.017). In conclusion, sildenafil and l-arginine were not effective to reduce intestinal injury.
- Subjects
ENTEROCOLITIS; NEONATAL necrotizing enterocolitis; ARGININE; NEONATAL intensive care units; SILDENAFIL; ANIMAL disease models
- Publication
Scientific Reports, 2022, Vol 12, Issue 1, p1
- ISSN
2045-2322
- Publication type
Article
- DOI
10.1038/s41598-022-10323-8